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Background and Purpose: It is necessary in clinical practice to screen patients with epilepsy for quality-of-life 
factors. The purpose of this study was to develop a Korean version of the Quality of Life in Epilepsy (QOLIE)-10 
survey and to determine its reliability and validity.
Methods: Data were collected from 397 adult epilepsy patients. The ten items of QOLIE-10 were derived from 
the Korean version of QOLIE-31. We assessed factor analysis, internal consistency, test-retest reliabilities, construct 
validity, and discriminant validity. Test-retest was performed in 97 patients.
Results: The ten items of QOLIE-10 were grouped into two factors: epilepsy effects/role function (driving, social, 
work, physical effect, mental effect, and memory) and mental health (overall quality of life, depression, and energy). 
The internal consistency reliability coefficient (Cronbach’s α) was 0.843 for epilepsy effects/role function and 0.606 
for the mental-health scale. Test–retest data revealed statistically significant correlations for individual items (range, 
r=0.66-0.38) and scales (range, r=0.63-0.48), except for one item, driving (r=0.21, p=0.133). QOLIE-10 was 
significantly correlated with the source scales in the Korean version of QOLIE-31 and with several external 
measures. The QOLIE-10 scores discriminated between patient groups according to their seizure severity and level 
of education.
Conclusions: QOLIE-10 was derived from the Korean version of QOLIE-31. The results of this study show that 
QOLIE-10 can be applied as a screening measure of quality of life in Korean epilepsy patients.
J Clin Neurol 2(4):238-245, 2006
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INTRODUCTION
Epilepsy produces recurrent and unpredictable 
seizures with substantial serious consequences on quality 
of life (QOL).
1 Patients with epilepsy are exposed to 
a host of social difficulties such as stigma and 
discrimination.
2  The World Health Organization (WHO) 
has defined health as the state of complete physical, 
mental, and social well-being, not merely as the absence 
of disease or infirmity.
3 Therefore, determining the 
health status of a patient should include the domains 
listed for the WHO’s definition of QOL.
In the outpatient clinic, physicians generally pay more 
attention to how well patients are doing,” depending 
exclusively on laboratory values and other medical Lee SA, et al. Reliability and Validity of the Korean Version of QOLIE-10 
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symptoms, with much less attention being paid to “how 
patients feel and function in everyday life.” Con-
sequently, patients and physicians often view the impact 
of seizures and side effects differently. Using a 
questionnaire as part of clinical care for patients allows 
them to depict their concerns about a variety of issues 
influenced by the diagnosis, including seizure frequency, 
fear of seizures, medication effects, and impact on daily 
life. Various instruments are available for the assessment 
of aspects of health-related QOL (HRQOL) in adults.
4-9 
HRQOL can be assessed by disease-specific inventories, 
as well as by more general or generic QOL inven-
tories.
4-9 Unlike diagnostic or laboratory tests that report 
whether a patient’s results are within the normal range, 
QOL instruments indicate how an individual functions in 
the real world (e.g., work and social opportunities, 
driving, independent living, fear of having a seizure).
10
To improve the specificity of information, generic 
questionnaires need to be modified for special popula-
tions, such as people with epilepsy, with supplementary 
items relevant to problems typically experienced by that 
population.
5,11,12 These are designed to reflect the patient’s 
own perception of how they feel about their disease. The 
Quality of Life in Epilepsy 31 (QOLIE-31) survey,
13 
which was designed to assess epilepsy-specific QOL 
issues, has been translated into several languages 
including Korean,
14 which allows its use in multinational 
clinical trials and other studies of HRQOL.
There is a need for screening questions that aim to 
improve communication and raise particular issues 
between patients and physicians. QOLIE-10,
15  which is 
a brief, ten-item questionnaire, was therefore developed 
to screen QOL issues for patients with epilepsy in 
clinical practice. QOLIE-10 provides individual patients 
with an opportunity to announce epilepsy-related 
problems and express their concerns to healthcare 
providers. The purpose of this study was to develop the 
Korean version of QOLIE-10 as a disease-specific 
screening measure of the QOL of Korean epilepsy 
patients. Thus, the reliability and validity of QOLIE-10 
derived from the Korean version of QOLIE-31 were 
evaluated in this study.
MATERIALS AND METHODS
1. Subjects
Data were collected from 397 adult epilepsy patients 
(60.4% male; mean age 31.2 years, range 17-65 years). 
Patients were recruited from five epilepsy centers in 
Korea. Criteria for inclusion were as follows: (1) being 
aged 17-65 years, (2) minimum of 1 year since diagnosis 
of epilepsy, (3) seizure-free for the previous 24 hours at 
the time of recruitment, and (4) a full-scale intelligence 
quotient (IQ) score higher than 80. The full-scale IQ 
measure derived from the revised and standardized 
version of the Korean Wechsler Intelligence Scale
16  was 
used. All types of epilepsy were included. Patients were 
excluded if (1) they had an active psychiatric, neuro-
logical, or medical disorder that would impair judgment 
or impact QOL beyond the effects caused by epilepsy, 
(2) they had a change in their regimen of antiepileptic 
drugs in the past 2 months, (3) they had brain surgery 
in the past year, or (4) they used a concomitant medi-
cation that has central nervous system effects. The 
detailed demographic and clinical characteristics of 
the sample are given in Table 1.
2. HRQOL assessment
HRQOL was assessed by administering the Korean 
version of QOLIE-31.
14  For examination of the test- 
retest reliability, an interval of 2 or 3 between each 
assessment was chosen so as to minimize the subject’s 
recall of previous answers.
17 Test–retest was performed 
in 97 patients. The Korean components of QOLIE-10 
were derived from the Korean version of QOLIE-31.
3. QOLIE-31 questionnaire
QOLIE-31
13  is a 31-item self-administered question-
naire designed for completion by patients alone, and was 
derived from QOLIE-89.
7 QOLIE-31 contains seven 
multi-item scales that cover the following health 
concepts: seizure worry (five items), overall QOL (two 
items), emotional well-being (five items), energy/fatigue Journal of Clinical Neurology: Vol. 2, No. 4, 2006
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Variable
Age, years, mean (SD) 32.2 (9.8)
Sex
Male
Female
239 (60.4%)
158 (39.6%)
Duration of education, years, mean (SD)
Elementary
Middle
High
University
12.6 (2.7)
21  (5.3%)
35  (8.8%)
191 (48.1%)
150 (37.8%)
Marital status
Currently married
Not married
Divorced, widowed, or separated
142 (36.8%)
232 (60.1%)
12   (3.1%)
Employment
Employed
Unemployed
223 (61.8%)
138 (38.2%)
Economic status
High
Middle
Low
  34 (9.3%)
213 (58.4%)
118 (32.3%)
Mean age at onset, years, mean (SD) 18.5 (9.9)
Type of epilepsy
Idiopathic generalized
Symptomatic (probably symptomatic) focal
Undetermined
Others
64  (16.2%)
267 (67.2%)
29   (7.3%)
37   (9.3%)
Seizure frequency
Remission for ≥2 years
Rare: <1 year
Moderate: 1-11 times/year
Frequent:  ≥1/month
19   (4.8%)
122 (32.3%)
156 (41.2%)
100 (26.4%)
Full-scale intelligence quotient, mean (SD) 103.0 (12.7)
Antiepileptic drug treatment
Monotherapy
Polytherapy
No therapy
166 (41.8%)
215 (54.2%)
16   (4.0%)
Table 1. Demographic and clinical characteristics of the sample
(four items), cognitive functioning (six items), medi-
cation effects (three items), and social functioning (five 
items). QOLIE-31 also includes a single item that 
assesses overall health. Responses can be scored to 
provide subscale scores and a total score. Higher scores 
in QOLIE-31 reflect a better QOL.
We completed the adaptation process of QOLIE-31 
into a Korean version. During development, the Korean 
version of QOLIE-31 was found to have good psycho-
metric properties.
14 Internal consistency reliability 
coefficients (Cronbach’s α) ranged from 0.69 (overall 
QOL) to 0.86 (seizure worry). The test-retest reliability 
was acceptable (range r=0.50-0.71). Item-to-scale co-
rrelations were calculated for 30 items comprising seven 
scales, and were uniformly very high for all scales: 
seizure worry (r=0.61-0.76), overall QOL (r=0.72-0.74), 
emotional well-being (r=0.38-0.49), energy/fatigue 
(r=0.37-0.42), cognitive functioning (r=0.45-0.72), 
medication effect (r=0.51-0.73), and social function 
(r=0.41-0.67). The Korean version of QOLIE-31 was 
sensitive to differences in seizure frequency and severity 
categories.
14
4. QOLIE-10 questionnaire
QOLIE-10 was derived from QOLIE-31.
13  QOLIE-10 
comprises seven components: five of them correspond to 
a single item from each of five subscales (seizure worry, 
overall QOL, emotional well-being, energy/fatigue, and 
cognitive functioning), one component includes two 
items on medication effects (physical effects and mental 
effects), and the last component includes three items on 
social function (work, driving, and social limits).
15 Thus, 
QOLIE-10 had ten items drawn from seven QOLIE-31 
scales.
14
5. Tests administered for constructive validity
  (1) Functional Assessment of Chronic Illness Therapy 
(FACIT)
The term “FACIT” aims to portray an expansion of 
the more familiar “FACT” series of questionnaires 
describing other chronic illnesses and conditions 
(e.g., multiple sclerosis, human immunodeficiency virus 
infection, and Parkinson’s disease).
18 The measurement 
system, which has been under development since 1987, 
began with the creation of a generic core questionnaire, 
the Functional Assessment of Cancer Therapy-General 
(FACT-G).
19 The FACT-G is a 27-item compilation of 
general questions divided into 4 primary QOL domains 
(physical well-being, social/family well-being, emotional Lee SA, et al. Reliability and Validity of the Korean Version of QOLIE-10 
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Table 2. Correlation of each QOLIE-10 item with the source summary scale in QOLIE-31
Item in QOLIE-10 Source scale in QOLIE-31 Correlation of QOLIE-10 item with source scale*
Seizure worry Seizure worry (five items) 0.846 
Overall QOL Overall QOL (two items) 0.882 
Depression Emotional well-being (five items) 0.669 
Energy Energy/fatigue (four items) 0.718 
Memory Cognitive functioning (six items) 0.760 
Physical effect Medication effect (three items) 0.908 
Mental effect Medication effect (three items) 0.884 
Driving Social function (five items) 0.646 
Social Social function (five items) 0.844 
Work Social function (five items) 0.809 
*; All p<0.001
well-being, and functional well-being). Equivalent 
foreign-language versions of the FACIT questionnaires 
are now available in 24 languages, permitting cross- 
cultural comparisons of people from diverse back-
grounds.
19  A higher score in the FACT-G also reflects 
a better QOL.
(2) State-Trait Anxiety Inventory (STAI)
The most widely used measure of anxiety in its two 
distinct forms assesses state anxiety and trait anxiety. 
Only the scale of state anxiety was analyzed in this 
study. A higher score reflects a greater anxiety.
20
(3) Center for Epidemiological Studies-Depression 
scale (CES-D)
The CES-D is used for measuring depression in the 
general and nonpsychiatric population.
21  Scores on this 
scale range from 0 to 60, with higher scores reflecting 
a greater level of depression. A cut-off of 16 was used, 
with patients having a score of 16 or more being 
classified as having significant depressive symptoms.
22
6. Data analyses
Varimax rotation was selected for the factor analysis. 
Variables with a loading of ≥0.4 were included in 
subscales. Factor analysis was performed on ten items in 
the Korean version of QOLIE-10. We assessed the 
test-retest reliability of QOLIE-10 using Pearson co-
rrelation coefficients. Cronbach’s α coefficients were 
calculated for each scale. Construct validity was assessed 
by examining the relationship between individual items 
compared with the source subscales and other external 
measures such as FACT-G, STAI, and CES-D. 
Discriminant validity was assessed by association with 
clinical and demographic features of samples including 
seizure frequency, type of antiepileptic drug treatment, 
and level of education.
Probability values of p<0.05 were considered 
statistically significant. Statistical analysis was conducted 
with standard SPSS Statistical Analysis System (V. 12.0) 
software (Chicago, IL, USA) on a personal computer.
RESULTS
1. Correlation of QOLIE-10 items with the source scale in 
QOLIE-31
Table 2 lists the item correlations between QOLIE-10 
items and QOLIE-31 parent scales (range, 0.908-0.646). 
All correlations were statistically significant (p<0.001).
2. Factor analysis of QOLIE-10
Factor analyses of ten items yielded two factors with 
eigenvalues of >1.0. The first factor comprised three 
items (driving, social, and work) of social function, two 
items (physical and mental effect) of medication effect, 
one item (memory) of cognitive functioning, and one 
item (seizure worry) of seizure worry (Table 3). The 
second factor comprised one item each (overall QOL, Journal of Clinical Neurology: Vol. 2, No. 4, 2006
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Table 3. Factor analysis and reliability of QOLIE-10
　 Cronbach’s  α Percentage variance Test-retest Pearson correlation*
Epilepsy effects/role-function scale 0.843 36.5 0.629 
   Physical effect 0.484 
   Mental effect 0.537 
   M e m o r y 0.631 
   S e i z u r e  w o r r y 0.660 
   D r i v i n g 0.211 
   S o c i a l 0.449 
   W o r k 0.490 
Mental-health scale 0.606 20.1 0.484 
   Overall QOL 0.461 
   Depression 0.380 
   E n e r g y 　　 0.387 
*Test-retest was performed in 97 patients. All items except driving had less than six missing values. However, there were responses 
for the driving item from only 52 of the 97 patients. All p<0.001, except driving (p=0.133)
Table 4. Correlation of each item and scale of QOLIE-10 with FACT-G, STAI and CES-D
FACT-G
STAI* CES-D*
　 Overall* Physical* Social
† Emotional* Functional*
QOLIE-10 -0.602 -0.526 -0.283 -0.541 -0.496  -0.630  -0.559 
   Epilepsy effects/role function scale -0.516  -0.478  -0.230  -0.495  -0.394  -0.547  -0.481 
      Physical effect -0.338  -0.334  -0.133  -0.360  -0.232  -0.356  -0.283 
      Mental effect -0.340  -0.282  -0.159  -0.332  -0.274  -0.392  -0.309 
      Memory -0.403  -0.364  -0.217  -0.342  -0.309  -0.439  -0.396 
      Seizure worry -0.461  -0.474  -0.145  -0.512  -0.324  -0.479  -0.409 
      Driving -0.326  -0.290  -0.220  -0.285  -0.217  -0.240  -0.295 
      Social -0.429  -0.375  -0.193  -0.380  -0.369  -0.474  -0.434 
      Work -0.393  -0.367  -0.160  -0.359  -0.326  -0.437  -0.366 
      Mental-health  scale -0.595 -0.430 -0.320 -0.449 -0.583  -0.608  -0.554 
      Overall QOL -0.506  -0.393  -0.273  -0.397  -0.471  -0.545  -0.450 
      Depression -0.480  -0.364  -0.229  -0.427  -0.443  -0.492  -0.488 
      Energy -0.385  -0.255  -0.233  -0.221  -0.417  -0.377  -0.326 
*; All p value <0.001, 
†; All p value <0.001 except seizure worry, driving, work, physical effect and mental effect p <0.01
depression, and energy) from overall QOL, emotional 
well-being, and energy/fatigue scales. Based on the 
content of items loading on each factor, the first factor 
was labeled as epilepsy effects/role function and the 
second factor was labeled as mental health. Scales were 
derived for each of these factors by summing the raw 
scores for each item that loaded at >0.40 on each factor.
3. Reliability of QOLIE-10
Internal consistency reliability coefficients (Cron-
bach’s  α) were 0.843 for epilepsy effects/role function 
and 0.606 for the mental-health scale (Table 3). 
Test-retest data revealed statistically significant 
correlations for individual items (range, r=0.66-0.38) 
and scales (range, r=0.63–0.48), except for one item, 
driving (r=0.21,  p=0.133).
4. Constructive validity
Correlation coefficients between QOLIE-10 and 
FACT-G, STAI, and CES-D questionnaires are 
presented in Table 4. The summary score of QOLIE-10 
was strongly correlated with FACT-G, STAI, and 
CES-D (range, r=-0.63 to -0.56). STAI and CES-D were 
most strongly correlated with the mental-health Lee SA, et al. Reliability and Validity of the Korean Version of QOLIE-10 
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Table 5. Differences in QOLIE-10 according to the degree of seizure frequency and education
Seizure frequency
p 
<1/year 1–11/year ≥1/year
QOLIE-10 68.5 (19.7) 57.9 (18.8) 56.8 (19.1) <0.001
   Epilepsy effects/
      role-function scale
72.8 (21.7) 58.5 (27.4) 58.3 (24.5) <0.001
   Mental-health scale 58.8 (19.7) 55.8 (18.8) 53.9 (15.5) 0.131
Antiepileptic drug therapy 　
Monotherapy Polytherapy
QOLIE-10 66.3 (21.1) 57.0 (19.4) <0.001
   Epilepsy effects/
      role-function scale
69.5 (25.0) 58.1 (25.0) <0.001
   Mental-health scale 58.7 (19.7) 54.3 (17.3) 0.02
Education
Elementary/
middle school
High school University
QOLIE-10 56.2 (21.0) 59.9 (22.4) 64.7 (17.5) 0.015
   Epilepsy effects/
      role-function scale
58.0 (24.7) 61.2 (28.0) 68.2 (21.8) 0.011
   Mental-health scale 52.2 (21.1) 56.8 (18.6) 56.7 (17.2) 0.174
Data are mean (SD) values
QOLIE-10 subscale (r=-0.61 and r=-0.55, respectively), 
where a negative correlation represents higher levels of 
anxiety or depression and worse QOL status, whereas 
they were poorly correlated with driving and physical- 
effect items (range, r=-0.22 to -0.36). These findings 
indicate convergent and divergent validities of QOLIE-10.
5. Discriminant validity
Several variables were significantly associated with a 
summary or with the subscale scores of QOLIE-10, 
including seizure frequency, antiepileptic drug therapy, 
and level of education (Table 5). Patients who suffered 
less than one seizure per year had significantly higher 
scores on QOLIE-10 than did patients who suffered at 
least one seizure per year. Moreover, patients receiving 
monotherapy for their epileptic condition or with a 
higher level of education were associated with higher 
scores on QOLIE-10. However, the mental-health 
subscale of QOLIE-10 was not related to seizure 
frequency or level of education. Other variables were not 
significant, including gender, age, age at onset, duration 
of epilepsy, or type of epilepsy.
DISCUSSION
Our data revealed a good correlation between the 
items of QOLIE-10 and their source scales in the 
Korean version of QOLIE-31. They also showed similar 
internal consistency and test-retest reliability as those 
reported by Cramer et al.
15  The Korean version of 
QOLIE-10 was strongly correlated with external 
measures such as FACT-F, STAI, and CES-D. These 
findings indicated the constructive validity of our 
QOLIE-10 questionnaire. In addition, QOLIE-10 could 
discriminate among patients according to their seizure 
severity and level of education. These data suggest the 
usefulness of the Korean version of QOLIE-10 as a 
screening tool in clinical practice.
The ten items of the original QOLIE-10 fall into three 
categories based on the content of items loading on each Journal of Clinical Neurology: Vol. 2, No. 4, 2006
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factor: (1) epilepsy effects (three items), (2) role 
function (four items), and (3) mental health (three 
items).
13 Compared to the original version, the factor 
analyses of the Korean version of QOLIE-10 in this 
study yielded two factors: (1) epilepsy effects/role 
function (seven items), and (2) mental health (three 
items). The items that constituted the mental-health 
factor in the original QOLIE-10 (overall QOL, 
depression, and energy) were identical to those of this 
factor in the Korean version of QOLIE-10. The items 
that constituted the epilepsy-effects and role-function 
factors in the original QOLIE-10 were not divided as 
two separate factors, instead being loaded onto one 
factor in this study.
Test-retest data demonstrated statistically significant 
reliability for individual items and scales of the Korean 
version of QOLIE-10, except for one item, driving. In 
this study, test-retesting was performed on 97 patients. 
All items except driving had less than six missing 
values. However, there were responses for the driving 
item from only 52 of the 97 patients. Such a large 
number of missing values for this item was probably the 
reason why the test-retest reliability for driving was not 
statistically significant.
McHorney et al.
23  compared the validity and relative 
precision in assessing constructs between six general- 
health-status instruments. They found that relative 
precision estimates favored long-form over short-form 
(SF) multi-item scales, and favored multi-item scales 
over single-item global measures and poster charts. 
Although the multi-item scales are expected to have 
higher reliability and validity, SF measures can be 
correlated well with longer instruments.
24 Our data 
demonstrated a good correlation between QOLIE-10 
items and their source scales in the Korean version of 
QOLIE-31. SF-12 has been recently released based on 
major items from the SF-36.
25 SF-12 has some 
similarities to QOLIE-10 in that it includes one or two 
items from each of the original subscales. Hurny et al.
26 
also supported the use of single-item scales in a 
comparison of a single-item and multi-item scales. They 
found correlations averaging 0.60 between single-item 
linear-analogue-scale questions for mood and a 28-item 
mood adjective scale.
The brevity of QOLIE-10 has the potential to save 
physician time without sacrificing the quality of 
information collected or interfering with the physician- 
patient relationship. Moreover, SF measures allow 
healthcare providers to assess a variety of issues without 
spending the extra time and resources required for the 
administration and scoring of longer instruments, and 
without requiring an extended interview to review all 
topics at every visit.
15
This study was subject to a limitation that was already 
pointed out by Cramer et al.
15 Patients included in this 
study were exposed to multiple questions for each 
subscale that gave a particular shape to the topic. This 
could have improved in the understanding of the single 
item in QOLIE-10 that represented the subscale. 
Separation of the ten items from QOLIE-31 may have 
resulted in patients having a worse appreciation of the 
issues, as with the multiple items. A separate study is 
needed in which QOLIE-10 items are presented before 
the remaining 21 items in QOLIE-31 to confirm these 
findings.
In summary, QOLIE-10 was derived from the Korean 
version of QOLIE-31 as a disease-specific screening 
measure of the QOL of Korean epilepsy patients, and its 
reliability and validity were confirmed. This study 
showed that it can be reliably applied as a screening 
measure of QOL in Korean epilepsy patients.
Appendix A
The Korean QoL in Epilepsy Study Group comprised 
the following people: Sang-Ahm Lee, M.D. (P.I.), 
Hee-Jung Yoo, Ph.D, and Joong-Koo Kang, M.D. 
(University of Ulsan College of Medicine, Seoul); 
Byung-In Lee, M.D., Kyoung Heo, M.D., and Ryeo 
Won Ko, Ph.D. (Yonsei University College of Medicine, 
Seoul); Sang-Do Yi, M.D. and Ju-Hwa Lee, Ph.D. 
(School of Medicine, Keimyung University, Daegu); 
Seung-Bong Hong, M.D. (School of Medicine, 
Sungkyunkwan University); and Jae-Moon Kim, M.D. 
(College of Medicine, Chungnam National University, 
Daejon).Lee SA, et al. Reliability and Validity of the Korean Version of QOLIE-10 
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